Pearl Abraham, PharmD, BCPS, BCOP

a { text-decoration: none; color: #464feb; } tr th, tr td { border: 1px solid #e6e6e6; } tr th { background-color: #f5f5f5; }
Pearl Abraham, PharmD, BCPS, BCOP is a board-certified Clinical Pharmacy Specialist in Hematology, Transplant, and Cellular Therapies, practicing primarily in the outpatient Multiple Myeloma Clinic. Dr. Abraham completed her PGY1 Pharmacy Residency at Texas Tech University Health Sciences Center Presbyterian Hospital in Dallas, Texas, and subsequently obtained board certifications in both Pharmacotherapy (BCPS) and Oncology Pharmacy (BCOP).
Passionate about advancing patient care and the pharmacy profession, Dr. Abraham is actively involved in the American Society for Transplantation and Cellular Therapy (ASTCT) and the Hematology/Oncology Pharmacy Association (HOPA). She is particularly enthusiastic about mentorship, precepting, and teaching, and enjoys supporting the development of pharmacy students, residents, and fellow healthcare professionals. Her professional interests include multiple myeloma, supportive care, cellular therapies, and promoting evidence-based approaches to optimize outcomes for patients with hematologic malignancies.
Financial relationships
-
Type of financial relationship:There are no financial relationships to disclose.Date added:08/24/2026Date updated:08/24/2026
**Disclaimer**
This Continuing Medical Education (CME) Learning Management System, Ethos, includes individuals designated as 'faculty' for CME purposes. Please note that the term 'faculty' refers solely to their role as a contributor/planner within a CME activity and does not imply any formal affiliation with UT Southwestern Medical Center (UTSW). The display of names and credentials is intended for educational purposes only and does not necessarily indicate a professional or academic relationship with UTSW. Participants are encouraged to verify the affiliations and credentials of faculty members independently if further clarification is needed.

Facebook
X
LinkedIn
Forward